Insulin Lispro Market

Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline in the beta chain of the insulin polypeptide.

Insulin Lispro Market contains market size and forecasts of Insulin Lispro in global, including the following market information:

• Global Insulin Lispro Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Insulin Lispro Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Insulin Lispro companies in 2021 (%)

The global Insulin Lispro market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Insulin aspart Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Insulin Lispro include Eli Lilly and Company and Gan & Lee Pharmaceuticals etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Insulin Lispro manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Insulin Lispro Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Lispro Market Segment Percentages, by Type, 2021 (%)

• Insulin aspart
• Mixed insulin aspart

Global Insulin Lispro Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Lispro Market Segment Percentages, by Application, 2021 (%)

• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Lispro Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Lispro Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Insulin Lispro revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Insulin Lispro revenues share in global market, 2021 (%)
• Key companies Insulin Lispro sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Insulin Lispro sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly and Company
• Gan & Lee Pharmaceuticals